The intention is that eventually the MHRA will operate as a sovereign regulator outside the EMA, but with regulatory equivalence and working closely with the EMA and other international partners.
We invite you to let us know what you think and join the debate by adding your comments below the essays or by tweeting using the hashtag NHSif. Nobel Prize winner Professor Sir Paul Nurse, Chief Executive of the Francis Crick Institute, has warned that Brexit could be a disaster for science in the UK because of its impact on the free movement of researchers across Europe and on the ability of UK researchers to attract research funding Ghosh Press release.
Entrants reserve all rights to their entries, but taking part in the competition implies accepting that The King's Fund retains unlimited rights to edit, reproduce and use your entry without further compensation.
Clarity about clinical trials regulations will be critical, particularly for research into rare diseases and paediatric medicine. The UK has furthered its scientific research agenda through EU collaboration, as a result of access to European research talent and to important sources of funding.
By entering, the entrants, including the winner, agree to allow the free use of their names, photographs and general locations for publicity and news purposes during this competition. In the event of a no-deal Brexit the government has said that the UK will recognise medical devices approved for the EU market and CE-marked and comply with other EU regulation for medical devices though will have no formal presence at EU committees in respect of devices.
The NHS is about being civilised; as we dismantle it, we become less civilised. This is the case whether they are set to gain from outsourcing and privatisation, or are merely captured by the shadows on the collective cave of our economic discourse.